1. Schryverde A, Friberg S, Klein G, et al. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol 1969; 5: 443?59.
2. Schryverde A, Klein G, Henle W, Henle G. EB virusassociated antibodies in Caucasian patients with carcinoma of the nasopharynx and in long term survivors after treatment. Int J Cancer 1974; 13: 319?25.
3. Henle W, Henle G, Ho HC, et al. Antibodies to Epstein-Barr virus in nasopharyngeal, other head and neck neoplasms, and control groups. JNCI 1970; 44: 225?31.
4. Henle W, Ho HC, Henle G, Kwan HC. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinomas: Comparison of active cases and long term survivors. JNCI 1973; 51: 361?9.
5. Lin TM, Yang CS, Ho SW. Antibodies to herpes type virus in nasopharyngeal carcinoma and control group in Taiwan. In: Recent Advances in Human Tumor Virology and Immunology. Tokyo: University of Tokyo Press, 1971: 309?15.